Algaktiv has introduced Exometics G, said to be the first patented vegan biomimetic exosomes for total skin renewal, at in-cosmetics Global stand 1D51.
The Spanish personal care ingredient maker says Exometics G is a revolutionary biomimetic exosome technology engineered from microalgae.
Offering unmatched regenerative power, Exometics G delivers superior skin renewal, elasticity, and anti-ageing benefits while overcoming the ethical, regulatory, and consumer concerns of first-generation exosomes.
Unlike currently available exosome solutions, which often provide unquantified and inconsistent vesicle concentrations, Exometics G is precisely dosed, with over 10 billion vesicles/mL.
This allows brands to claim above 10 millions of exosomes per drop in a formulated cream or serum, ensuring superior biological activity and efficacy in final formulations.
With patented bioengineering process, a controlled 150 nm particle size for optimal cell delivery, and unrivalled consistency, Exometics G is setting a new gold standard for next-generation skin care, says Algaktiv.
“We recognized that traditional exosome solutions had major limitations—from ethical concerns to batch variability and inconsistent efficacy,” added product director Jordi Ayats.
“With Exometics G, we have developed a patented technology that provides a standardized, high-potency, and clinically validated alternative, allowing brands to claim exosomal performance in their final formulations.”
